Article Details

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Rating of "Hold" by Analysts

Retrieved on: 2021-02-10 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Rating of "Hold" by Analysts. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 1,087,893 shares of the biopharmaceutical company's stock worth $10,508,000 after purchasing an ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up